Abdul W. Basit, Ph.D., is a Professor of Pharmaceutics at the University College London—School of Pharmacy. He is a world-leading authority on oral drug delivery, digital health, and innovative pharmaceutical technologies. He leads a large and multi-disciplinary group, where his research sits at the interface between microbiome, pharmaceutical 3D printing, digital health, and gastroenterology, forging links between basic science and clinical outcomes. He has founded two spin-out companies (FabRx and Intract Pharma) and has invented several drug products that have entered the clinic and benefit more than a million patients every year. He has published over 350 papers, book chapters, abstracts, and patents. Throughout his career, Abdul has received prestigious awards, including the Harrison Memorial Medal, AAPS’s Young Investigator, GSK’s Innovative Science Award, AstraZeneca’s Pharmaceutical Science Award, and APS’s Science Award. In 2019, 2020, and 2021, Abdul was listed among the World’s Most Highly Influential Researchers by Web of Science.